Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.14+0.04 (+0.17%)
Close on Nov 18, 2026Market cap $463.06MP/E –Yield –
Neurogene market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Neurogene's market cap was $397.35M on Nov 11, 2026, against $311.46M a year earlier. Over the last 5 years it ranged from $86.72M to $1.24B, with a median of $311.46M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $397.35M | +30.5% |
| 2025 | Dec 31, 2025 | $304.37M | +2.3% |
| 2024 | Dec 31, 2024 | $297.43M | +74.3% |
| 2023 | Dec 29, 2023 | $170.65M | +96.8% |
| 2022 | Dec 30, 2022 | $86.72M | -89.4% |
| 2021 | Dec 31, 2021 | $818.01M | -65.4% |
| 2020 | Dec 31, 2020 | $2.36B | +70.3% |
| 2019 | Dec 31, 2019 | $1.39B | +581.9% |
| 2018 | Dec 31, 2018 | $203.36M | -81.6% |
| 2017 | Dec 29, 2017 | $1.10B | -28.6% |
| 2016 | Dec 30, 2016 | $1.55B | +80.0% |
| 2015 | Dec 31, 2015 | $859.22M | +361.6% |
| 2014 | Dec 31, 2014 | $186.15M | – |
See a number that looks wrong?